For decades, cardiology in India functioned as a unified discipline, with the heart approached as a singular critical organ rather than a field divided into focused subspecialties. That structure has since shifted. The emergence of subspecialties, particularly interventional cardiology, marks a clear transition in how cardiovascular disease is approached and treated.
It is within this evolving framework that practitioners such as Dr. Johann Christopher have developed their careers, undergoing years of specialised training to manage increasingly complex cardiovascular conditions through targeted intervention.
From Primary Care to Cardiac Specialisation
Dr. Johann Christopher took off his medical journey with MBBS at Christian Medical College, Ludhiana, where he completed his formal training. His early professional years were shaped outside tertiary centres, beginning at a Primary Health Centre in Mathura, Uttar Pradesh. This was followed by a year at a cardiac super-speciality hospital in Nadiad, Gujarat.
These two settings offered distinct forms of exposure. The primary care environment in Mathura required management of a wide spectrum of conditions with limited resources whilst the specialised cardiac institution in Gujarat introduced him to advanced cardiovascular therapeutics at an early stage. This combination of broad-based clinical grounding and early subspecialty exposure informed his decision to pursue cardiology as a focused discipline. He subsequently undertook a structured six-year pathway culminating in a DNB in Cardiology from CARE Hospitals, Hyderabad.
Evolving Disease Patterns
Currently serving as Senior Consultant in Interventional Cardiology and Director of Cardiac Imaging at CARE Hospitals, Dr. Christopher’s practice covers both diagnostic and interventional domains.
Over the course of his career, he has worked within a healthcare system undergoing considerable transition. He remarked, “Since the early 1990s, the profile of cardiovascular disease in India has shifted significantly. Earlier patterns of rheumatic heart disease, predominantly seen in lower socio-economic groups, have gradually given way to atherosclerotic disease in more affluent populations, and eventually to ischemic heart disease across all sections of society. Parallel to this epidemiological shift has been the rise of heart failure as a frequent consequence of inadequately managed risk factors.”
Expansion of Interventional Practice
The expansion of interventional cardiology has been a defining feature of this period. What began as basic balloon angioplasty has progressed to complex structural heart interventions that are now routinely performed in advanced centres. This growth has altered both expectations and practice patterns, though access remains uneven across regions and populations.
Dr. Christopher notes that while interventional capabilities have expanded, they have not uniformly translated into accessibility. Even with the presence of government-supported schemes, a significant proportion of patients remain outside the reach of advanced procedures. At the same time, the availability of such interventions has led to instances where invasive approaches are adopted in cases that may be managed medically.
Diagnostic Challenges
In routine practice, the evaluation of coronary artery disease continues to present practical challenges. The variability in patient presentation, differences in acceptance of investigations, and the wide range of available diagnostic tools complicate standardisation. In this context, Dr. Christopher emphasises the need for a comprehensive understanding of the patient before selecting investigative pathways.
He describes this as a “Know Your Patient” approach, where clinical history, risk profile, and individual context guide the diagnostic process. This approach presents clinical clarity in busy outpatient settings where time and resources are often limited.
Defining the Treatment Threshold
The decision between medical management and interventional treatment remains a central consideration in cardiology practice. Evidence from large trials, including the COURAGE and ISCHEMIA studies, has reinforced the role of guideline-directed medical therapy in stable coronary artery disease.
Within this framework, the selection of patients for intervention requires careful evaluation rather than reliance on procedural availability. Dr. Christopher underscores that this decision is contingent on clinical judgment informed by experience, adherence to established guidelines, and an understanding of patient-specific factors.
Imaging Advances and Preventive Gaps
In the course of Dr. Christopher’s practice, advancements in imaging have altered diagnostic pathways in cardiology. Modalities such as echocardiography and CT angiography now function as data-intensive tools rather than purely visual assessments. They contribute to both diagnosis and prognostication, allowing for more precise clinical decisions. In addition to improving diagnostic accuracy, these technologies have enabled more accessible and cost-effective bedside evaluations.
Despite these advances, preventive cardiology continues to receive limited emphasis in practice. Dr. Christopher identifies structural and behavioural factors contributing to this gap, including lower perceived value compared to interventional procedures and limited engagement among younger practitioners.
In the Indian context, where access to healthcare remains uneven, preventive strategies are critical to reducing overall disease burden. Their implementation has direct implications for hospitalisation rates, long-term outcomes, and healthcare costs. Strengthening this area requires sustained attention at both institutional and policy levels.
Guidance for Emerging Cardiologists
For those entering the field, Dr. Christopher advises, “Cardiology demands a combination of analytical reasoning, imaging proficiency, and procedural skill. The discipline requires long-term commitment, continuous learning, and consistency in practice.
The trajectory of a cardiologist is shaped less by short-term achievements and more by sustained engagement with evolving clinical evidence and patient care. Recognition within the field follows from this continuity rather than isolated milestones.”
